• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一家三级护理医院中肺炎克雷伯菌产超广谱β-内酰胺酶和碳青霉烯酶血流分离株的患病率。

Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital.

作者信息

Abodakpi Henrietta, Chang Kai-Tai, Sánchez Díaz Ana María, Cantón Rafael, Lasco Todd M, Chan Katrina, Sofjan Amelia K, Tam Vincent H

机构信息

a Department of Pharmacological and Pharmaceutical Sciences , University of Houston College of Pharmacy , Houston , TX , USA.

b Department of Pharmacy Practice and Translational Research , University of Houston College of Pharmacy , Houston , TX , USA.

出版信息

J Chemother. 2018 Apr;30(2):115-119. doi: 10.1080/1120009X.2017.1399233. Epub 2017 Nov 10.

DOI:10.1080/1120009X.2017.1399233
PMID:29125052
Abstract

To improve prescribing of empiric therapy, the local molecular epidemiology of extended-spectrum beta-lactamases (ESBLs) and Klebsiella pneumoniae carbapenemases (KPCs) in bloodstream isolates of K. pneumoniae were evaluated. Isolates resistant to third generation cephalosporins were screened phenotypically for ESBLs and carbapenemases, and subsequently confirmed by PCR for the presence of ESBL (bla, bla and bla) and carbapenemase (bla, bla, bla and bla) genes. Hydrolytic activity (functional gene expression) was quantified using a nitrocefin degradation assay and correlated to ceftazidime or meropenem MIC. Clonality was assessed by repetitive element-based PCR. Beta-lactamases were functionally expressed in 13 isolates (15.5%); 7 (53.8%) harboured bla and 6 (46.2%) carried the bla gene. Correlation of hydrolytic activity to MIC yielded a coefficient of 98% for isolates expressing ESBLs alone and 56% for carbapenemase producers. Four unique ESBL-expressing clones and five carbapenem-resistant clones were identified. All 13 resistant isolates were susceptible to ceftazidime/avibactam (MIC ≤ 8/4 mg/L).

摘要

为改善经验性治疗的用药情况,对肺炎克雷伯菌血流分离株中广谱β-内酰胺酶(ESBLs)和肺炎克雷伯菌碳青霉烯酶(KPCs)的局部分子流行病学进行了评估。对耐第三代头孢菌素的分离株进行ESBLs和碳青霉烯酶的表型筛选,随后通过PCR确认ESBL(bla、bla和bla)和碳青霉烯酶(bla、bla、bla和bla)基因的存在。使用硝基头孢菌素降解试验对水解活性(功能基因表达)进行定量,并与头孢他啶或美罗培南的最低抑菌浓度(MIC)相关联。通过基于重复元件的PCR评估克隆性。13株分离株(15.5%)功能性表达β-内酰胺酶;7株(53.8%)携带bla,6株(46.2%)携带bla基因。水解活性与MIC的相关性显示,仅表达ESBLs的分离株系数为98%,碳青霉烯酶产生菌为56%。鉴定出4个独特的表达ESBLs的克隆和5个耐碳青霉烯的克隆。所有13株耐药分离株对头孢他啶/阿维巴坦敏感(MIC≤8/4 mg/L)。

相似文献

1
Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital.一家三级护理医院中肺炎克雷伯菌产超广谱β-内酰胺酶和碳青霉烯酶血流分离株的患病率。
J Chemother. 2018 Apr;30(2):115-119. doi: 10.1080/1120009X.2017.1399233. Epub 2017 Nov 10.
2
The emergence of bla and bla among ESBL-producing Klebsiella pneumoniae in clinical isolates of a tertiary hospital in Iran.伊朗一家三级医院临床分离株中产超广谱β-内酰胺酶肺炎克雷伯菌中bla和bla的出现情况。
Acta Microbiol Immunol Hung. 2018 Aug 1;65(3):335-344. doi: 10.1556/030.65.2018.034. Epub 2018 Jul 19.
3
An Outbreak of ESBL-producing Klebsiella pneumoniae in an Iranian Referral Hospital: Epidemiology and Molecular Typing.伊朗一家转诊医院产超广谱β-内酰胺酶肺炎克雷伯菌的暴发:流行病学与分子分型
Infect Disord Drug Targets. 2019;19(1):46-54. doi: 10.2174/1871526518666180507121831.
4
Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals.利雅得医院碳青霉烯类药物不敏感的大肠埃希菌和肺炎克雷伯菌中产碳青霉烯酶、ESBLs 和质粒介导喹诺酮类药物决定因子的特征。
J Infect Public Health. 2018 Jan-Feb;11(1):64-68. doi: 10.1016/j.jiph.2017.03.010. Epub 2017 Apr 24.
5
Prevalence and Molecular Epidemiology of Clinical Isolates of and Harboring Extended-Spectrum Beta-Lactamase and Carbapenemase Genes in Bangladesh.孟加拉国产 ESBL 和碳青霉烯酶基因的 和 临床分离株的流行率和分子流行病学。
Microb Drug Resist. 2018 Dec;24(10):1568-1579. doi: 10.1089/mdr.2018.0063. Epub 2018 Jun 29.
6
Contribution of upregulation & OmpC/Ompk36 loss over the presence of towards carbapenem resistance development among pathogenic spp.上调表达与 OmpC/Ompk36 缺失对临床致病性 spp. 产生碳青霉烯类耐药性的贡献
Indian J Med Res. 2019 Apr;149(4):528-538. doi: 10.4103/ijmr.IJMR_716_17.
7
Identification of Carbapenem-Resistant Klebsiella pneumoniae with Emphasis on New Delhi Metallo-Beta-Lactamase-1 (bla) in Bandar Abbas, South of Iran.伊朗南部阿巴斯港耐碳青霉烯类肺炎克雷伯菌的鉴定,重点关注新德里金属β-内酰胺酶-1(bla)
Microb Drug Resist. 2018 May;24(4):447-454. doi: 10.1089/mdr.2017.0058. Epub 2017 Oct 3.
8
Occurrence of OXA-48 and NDM-1 carbapenemase-producing Klebsiella pneumoniae in a Moroccan university hospital in Casablanca, Morocco.在摩洛哥卡萨布兰卡的一家大学医院中,产OXA-48和NDM-1碳青霉烯酶的肺炎克雷伯菌的出现情况。
Infect Genet Evol. 2015 Apr;31:142-8. doi: 10.1016/j.meegid.2015.01.010. Epub 2015 Jan 22.
9
The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia.沙特阿拉伯利雅得出现产 OXA-48 和 NDM-1 型阳性肺炎克雷伯菌。
Int J Infect Dis. 2013 Dec;17(12):e1130-3. doi: 10.1016/j.ijid.2013.06.016. Epub 2013 Aug 30.
10
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.耐碳青霉烯类肺炎克雷伯菌感染治疗期间因质粒介导的突变导致头孢他啶-阿维巴坦耐药的出现
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02097-16. Print 2017 Mar.

引用本文的文献

1
Silver Nanoparticles as Antibacterials: Synthesis, Characterization, and Molecular Simulations Against β-Lactamase-Producing Enterobacter and Salmonella spp.银纳米颗粒作为抗菌剂:针对产β-内酰胺酶的肠杆菌属和沙门氏菌属的合成、表征及分子模拟
Mol Biotechnol. 2025 May 6. doi: 10.1007/s12033-025-01445-1.
2
In Vitro Dynamic Model Evaluation of Meropenem Alone and in Combination with Avibactam Against Carbapenemase-Producing .美罗培南单独及与阿维巴坦联合对产碳青霉烯酶菌株的体外动态模型评估
Pharmaceuticals (Basel). 2024 Dec 13;17(12):1683. doi: 10.3390/ph17121683.
3
Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae.
针对产 KPC 肺炎克雷伯菌的最佳头孢他啶/阿维巴坦给药暴露量。
J Antimicrob Chemother. 2022 Oct 28;77(11):3130-3137. doi: 10.1093/jac/dkac294.
4
Hydrolytic activity of KPC-producing clinical isolates.产KPC临床分离株的水解活性。
J Chemother. 2022 Sep;34(5):345-346. doi: 10.1080/1120009X.2021.2004363. Epub 2021 Nov 22.
5
Drug Susceptibility and Molecular Epidemiology of Bloodstream Infection in ICU Patients in Shanghai, China.中国上海重症监护病房患者血流感染的药物敏感性与分子流行病学
Front Med (Lausanne). 2021 Oct 13;8:754944. doi: 10.3389/fmed.2021.754944. eCollection 2021.
6
A Genomic Approach To Identify Klebsiella pneumoniae and Acinetobacter baumannii Strains with Enhanced Competitive Fitness in the Lungs during Multistrain Pneumonia.一种基因组方法,用于鉴定在多菌株肺炎期间肺部具有增强竞争适应性的肺炎克雷伯菌和鲍曼不动杆菌菌株。
Infect Immun. 2019 May 21;87(6). doi: 10.1128/IAI.00871-18. Print 2019 Jun.
7
Optimal Piperacillin-Tazobactam Dosing Strategies against Extended-Spectrum-β-Lactamase-Producing .优化哌拉西林-他唑巴坦治疗产超广谱β-内酰胺酶的剂量策略。
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.01906-18. Print 2019 Feb.